GENE ONLINE|News &
Opinion
Blog

Gene Therapy
Beam Therapeutics Acquires Georgia Tech Spin Out, Seeks Non-Viral Gene Therapy Delivery Vehicles
2021-02-25
Charles River Labs Expands Manufacturing Capabilities Through CDMO Acquisition
2021-02-23
Researchers Test Gene Augmentation Therapy in Patient-Derived Retinal Organoids to Find Eye Disease Cure
2021-02-23
Bluebird Bio Temporarily Suspends Sickle Cell Trials Following Cancer Diagnosis in Two Patients
2021-02-18
George Church’s New Startup Engineers AAV Vectors that Evades Host Immune Responses
2021-02-17
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Sana Biotechnology Makes Wall Street Debut with $587.5 Million IPO
2021-02-05
Daiichi Sankyo Collaboration Marks ViGeneron’s Second Gene Therapy Deal in a Single Month
2021-01-19
Tessera Raises $230M to Develop ‘Gene Writing’ into Novel Genetic Therapy
2021-01-15
JPM Healthcare Conference Highlights: Editas Upbeat about EDIT-101 Success, Verve Continues to Tackle Cholesterol
2021-01-15
Sarepta’s Stocks Drop 50% Following Middling Trial Data for Gene Therapy
2021-01-11
uniQure’s Hemophilia B Gene Therapy Put on Clinical Hold by the FDA
2020-12-22
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
2020-12-17
Why is Eli Lilly Seeking Prevail’s Gene Therapy Pipeline?
2020-12-17
1 5 6 7 8 9
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top